Misi BioLabs
All articles

2 min readBlood Biomarkers

A blood test that may flag depression risk before symptoms appear

Depression is usually diagnosed after symptoms are already disrupting someone’s life. A 2026 study on immune-cell aging in the blood suggests a biological signal may be detectable earlier than that.

Part 17 of 26This article is part of the Blood Biomarkers guide
Source studyScienceDaily: this simple blood test might detect depression before symptoms appear (May 2026)

Beaulieu Perez N, et al. "Monocyte Epigenetic Age Acceleration is Linked to Non-Somatic Depressive Symptoms in Women with and Without HIV." The Journals of Gerontology, Series A, 2026. View study →

Mental health diagnosis has historically relied almost entirely on symptom questionnaires and clinical interviews — there has been no equivalent of a cholesterol panel for depression risk. A 2026 study exploring biological aging in immune cells (monocytes) suggests that may be starting to change.

What the researchers were measuring

The study looked at signs of accelerated biological aging specifically within monocytes, a type of white blood cell heavily involved in the body’s inflammatory response. Elevated monocyte aging markers were associated with subsequent depression risk, raising the possibility that a measurable, blood-based inflammatory-aging signal precedes the clinical symptoms that currently define a diagnosis.

The inflammation-depression connection is not new — the timing angle is

The link between chronic inflammation and depression has been studied for years — elevated inflammatory markers are a well-replicated finding in people with depression. What is newer here is the suggestion that this signal, measured through immune-cell aging specifically, might be detectable before symptoms are clinically apparent, which would open the door to earlier intervention rather than a purely reactive, post-diagnosis approach.

The provocative part of this finding is not that inflammation and depression are linked — that is established. It is the suggestion that the biological signal may show up before the symptoms do.

What this means practically, today

This is not yet a validated clinical screening test, and nobody should interpret a single blood marker as a depression diagnosis or its absence as reassurance. What it does reinforce is a theme running through nearly all of this year's biomarker research: chronic, low-grade inflammation is a common thread across cardiovascular, metabolic and now potentially mental health risk — which makes hs-CRP and similar markers worth tracking as a general health signal, not just a heart-disease number.

Misi is a coaching and wellness platform, not a medical service, and does not diagnose or screen for depression or any mental health condition. If you are experiencing symptoms of depression or low mood, please speak with a qualified healthcare professional.

Ready to put this into practice?

Misi BioLabs turns your bloods into a meal plan, training block and AI coaching — in one place.

Start free

Get evidence-led longevity writing in your inbox

One concise, cited email when we publish. No spam, unsubscribe anytime.

Free tools

Found this useful? Share it.